Melissa Middeldorp

School of Medicine

College of Health


Dr Middeldorp completed her PhD in May 2019, with a focus on risk factors for Atrial Fibrillation. She moved to the United States in July 2021 to undertake a postdoctoral fellowship at Cedar Sinai Medical Centre, Los Angeles and is currently at the University Medical Centre Groningen, Netherlands. In May 2022 she graduated with her Masters in Public Health at Harvard University. Her research focus on the management of cardiovascular risk factors in patients with atrial fibrillation through individualised, structured clinics. Additionally, her research is focusing on the differences in outcomes between men and women with atrial fibrillation particularly outcomes, complications and treatment strategies.

Dr Middeldorp is a research scientist with a particular interest in:

1. Risk factors and the relationship with atrial fibrillation.

2. Gender differences in atrial fibrillation outcomes.

3. Ablation outcomes in patients with atrial fibrillation.

AVAILABLE PROJECTS FOR HONOURS/PHD STUDENTS

Below is a list of several projects available within our group. This list is not exhaustive and any prospective students should contact Dr Middeldorp in the first instance:

1. Atrial Fibrillation and Risk Factor Clinics.

Investigating the role of dedicated risk factor clinics to manage patients individual risk factors to improve symptoms, reversal of the disease process and outcomes in patients with atrial fibrillation.

2. Is There a Role that Gender Plays in Patients with Atrial Fibrillation.

There is much discrepancy in the role gender plays particularly regarding ablation outcomes. Currently we are running an ongoing registry of ablation patients to be able to distinguish if there is a difference and what particularly in the long term.

Date Position Institution name
2023 - ongoing Postdoctoral Research Fellow University Medical Centre of Groningen
2021 - 2023 Postdoctoral Research Fellow Cedars-Sinai Medical Center
2019 - 2021 Postdoctoral Research Fellow University of Adelaide

Date Type Title Institution Name Country Amount
2024 Scholarship HRX Allied Professional Travel Scholarship Heart Rhythm Society United States -
2023 Award Circulation Journal Outstanding Reviewer Award American Heart Association United States -
2023 Award European Heart Journal Top Reviewer Award European Heart Journal France -
2023 Award Highest Scoring Women in EP Abstract award Heart Rhythm Society United States -
2022 Award European Heart Journal Top Reviewer Award European Heart Society Spain -
2021 Fellowship Cedar-Sinai Postdoctoral Fellowship Cedar-Sinai Medical Centre, Smit Heart Institute United States -
2020 Award SA Science Excellence and Innovation PhD Excellence Award - Finalist Government of South Australian - Department for Skills and Innovation Australia -
2019 Scholarship European Society of Cardiology Educational Grant European Society of Cardiology France -
2019 Award Dean's Commendation for Doctoral Thesis Excellence University of Adelaide Australia -
2018 Award Medical Staff Society Research Prize Royal Adelaide Hospital Australia -
2018 Award AHM Research Travel Award University of Adelaide Australia -
2017 Award Best Moderated Poster Award – AF Ablation outcomes and predictors ESC - European Society of Cardiology Congress Spain -
2017 Award EO Myers Trust Fund Travel Scholarship National Heart Foundation Australia -
2015 Scholarship Robert J. Craig Scholarship University of Adelaide Australia -
2013 Award Highest Scoring Abstract in Allied Health Heart Rhythm Society United States -

Language Competency
English Can read, write, speak, understand spoken and peer review

Date Institution name Country Title
2022 Harvard University, Harvard T Chan School of Public Health United States MPH
2019 University of Adelaide Australia PhD

Date Title Institution name Country
2009 Certificate IV in Emergency Care SA Ambulance Service Australia
2009 Certificate II in Emergency - Medical service first response SA Ambulance Service Australia
2006 Certificate III in Business Administration Buisness SA Australia

Year Citation
2025 Jared Bunch, T., Antman, E., Catanzaro, J. N., Deneke, T., Freeman, J. V., Edip Gurol, M., . . . Deering, T. F. (2025). Criteria for the establishment of an atrial fibrillation center of excellence and key operational standards. Heart Rhythm, 22(8), e544-e562.
DOI
2025 Evans, S., Howson, S. A., Booth, A. E. C., Shahmohamadi, E., Lim, M., Bacchi, S., . . . Sanders, P. (2025). Artificial intelligence electrocardiogram-predicted biological age gap and mortality: Capturing dynamic risk with multiple electrocardiograms. Heart Rhythm, 22(9), e710-e716.
DOI Scopus1 WoS1
2025 Gunawardene, M. A., Middeldorp, M. E., & Sanders, P. (2025). Obstructive path to sinus rhythm: When COPD undermines AF ablation success. Indian Pacing and Electrophysiology Journal, 25(3), 157-158.
DOI
2025 Gunawardene, M. A., Middeldorp, M., Pape, U. -F., Maasberg, S., Hartmann, J., Dickow, J., . . . Willems, S. (2025). Esophageal endoscopic findings after pulmonary vein and posterior wall isolation using pulsed field ablation - Results from the Eso-PFA study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 27(8), euaf133.
DOI Scopus2 WoS1
2025 Howie, J. O., Dziano, J. K., Ariyaratnam, J. P., Abbas, M., Kenny, G. T., Evans, S., . . . Elliott, A. D. (2025). The Association of Age and Left Atrial Dysfunction in Patients with Atrial Fibrillation. Heart Rhythm, 22(12), 1-9.
DOI
2025 Shahmohamadi, E., Puvrez, A., & Middeldorp, M. E. (2025). Weight for Rhythm: Is the Evidence for AF Risk with Semaglutide Still Premature?. Eur J Prev Cardiol, 2 pages.
DOI WoS2 Europe PMC1
2025 Middeldorp, M. E., van Deutekom, C., Weil, L. I., Van Gelder, I. C., De Ruijter, U. W., Jeurissen, P. T., . . . Rienstra, M. (2025). Sex differences in hospitalisation and healthcare utilisation for patients with atrial fibrillation Middeldorp et al. Sex differences in healthcare utilisation and AF. Ijc Heart and Vasculature, 60, 6 pages.
DOI Scopus1
2025 Middeldorp, M. E., van Deutekom, C., Weil, L. I., De Ruijter, U. W., Jeurissen, P. T., Van Gelder, I. C., . . . Rienstra, M. (2025). Hospital healthcare utilisation in patients with atrial fibrillation: the role of multimorbidity and age. Netherlands Heart Journal, 33(9), 270-280.
DOI
2025 Sanders, P., Ariyaratnam, J. P., Puvrez, A., Middeldorp, M. E., Nicholls, S. J., Thomas, G., . . . Kalman, J. M. (2025). Cardiac Resynchronization Therapy And AV Node Ablation in Heart Failure with Reduced Ejection Fraction and Atrial Fibrillation. Rationale and Design of the CAAN-AF trial. Heart Rhythm O2, 6(11), 1-9.
DOI
2025 Dziano, J. K., Ariyaratnam, J. P., Middeldorp, M. E., Sanders, P., & Elliott, A. D. (2025). Obesity and Atrial Fibrillation: From Mechanisms to Treatment. Heart Lung and Circulation, 34(10), 1021-1032.
DOI Scopus1 WoS1
2025 Ariyaratnam, J. P., Elliott, A. D., Mishima, R. S., Dziano, J. K., Emami, M., Howie, J. O., . . . Sanders, P. (2025). Evaluating the Impact of Obesity and Epicardial Adiposity on the Presence of HFpEF in Patients With AF.. JACC Clin Electrophysiol, S2405-500X(25)00703-0.
DOI
2025 Pathak, R. K., Elliott, A. D., Lau, D. H., Middeldorp, M. E., Linz, D., Fitzgerald, J. L., . . . Sanders, P. (2025). Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes: The ARREST-AF Randomized Clinical Trial.. JAMA Cardiol, 10(12), 10 pages.
DOI
2025 Middeldorp, M. E., & Shahmohamadi, E. (2025). Semaglutide After Catheter Ablation: A New Chapter in Atrial Fibrillation Care?. Circulation Arrhythmia and Electrophysiology, 18(11), e014508.
DOI
2025 Kakarla, S., Emami, M., Puvrez, A., Young, G. D., Ariyaratnam, J., Kamsani, S., . . . Sanders, P. (2025). Update on First-in-Human Experience of High-Energy ElectroPulse Pulsed Field Ablation.. Heart Rhythm, S1547-5271(25)03030-9.
DOI
2025 Middeldorp, M. E., Thomas, G., Kamsani, S. H., Harper, C., Baykaner, T., Gopinathannair, R., . . . Sanders, P. (2025). Use of artificial intelligence algorithms to reduce transmissions in implantable loop recorders. Heart Rhythm, 22(7), e241-e243.
DOI Scopus1 Europe PMC1
2025 Kadhim, K., Elliott, A. D., Middeldorp, M. E., Nalliah, C. J., McEvoy, R. D., Antic, N. A., . . . Sanders, P. (2025). Development of a Multivariable Prediction Model to Estimate Probability of Sleep-Disordered-Breathing in Patients With AF: MOODS-AF. JACC: Clinical Electrophysiology, 11(2), 309-317.
DOI Scopus3 WoS3 Europe PMC3
2025 Evans, S., Howson, S. A., Booth, A. E. C., Shahmohamadi, E., Lim, M., Bacchi, S., . . . Sanders, P. (2025). Artificial intelligence age prediction using electrocardiogram data: Exploring biological age differences. Heart Rhythm, 22(6), 1492-1497.
DOI Scopus3 WoS2 Europe PMC1
2025 Middeldorp, M. E., Manson, J. E., Aragaki, A. K., Clar, A., Sesso, H. D., & Albert, C. M. (2025). Cocoa flavanol supplementation and incident atrial fibrillation in the COSMOS trial. European Journal of Preventive Cardiology, 32(16), 1671-1673.
DOI
2024 Elliott, A. D., Middeldorp, M. E., McMullen, J. R., Fatkin, D., Thomas, L., Gwynne, K., . . . Australian Cardiovascular Alliance (ACvA) Atrial Fibrillation Working Group. (2024). Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme.. Heart, lung & circulation, 33(11), S1443-9506(24)01800-6.
DOI Scopus2 WoS2 Europe PMC2
2024 Gawałko, M., Middeldorp, M. E., Saljic, A., Penders, J., Jespersen, T., Albert, C. M., . . . Linz, D. (2024). Diet and risk of atrial fibrillation: a systematic review. European Heart Journal, 45(40), 4259-4274.
DOI Scopus6 WoS7 Europe PMC5
2024 Middeldorp, M. E., & Sandhu, R. K. (2024). The stroke enigma: decoding the sex risk factor in atrial fibrillation. European Heart Journal, 45(2), 114-116.
DOI Scopus5 WoS5 Europe PMC3
2024 Ariyaratnam, J. P., Middeldorp, M. E., Brooks, A. G., Thomas, G., Kadhim, K., Mahajan, R., . . . Sanders, P. (2024). Coronary Sinus Isolation for High Burden Atrial Fibrillation. A Randomized Clinical Trial. JACC: Clinical Electrophysiology, 11(1), 1-9.
DOI Scopus2 WoS2 Europe PMC3
2024 Middeldorp, M. E., Sandhu, R. K., Mao, J., Gencer, B., Danik, J. S., Moorthy, V., . . . Albert, C. M. (2024). Highlights From the <i>Circulation</i> Family of Journals. CIRCULATION, 149(8), 627-632.
DOI
2024 Kamsani, S. H., & Middeldorp, M. E. (2024). Adherence in a fortnight: is this a true reflection of a lifetime?. Heart, 110(9), 615-617.
DOI
2024 Noubiap, J. J., Nyaga, U. F., Middeldorp, M. E., Stokes, M. B., & Sanders, P. (2024). Cardiac imaging correlates and predictors of stroke in patients with atrial fibrillation: a meta-analysis. Journal of Cardiovascular Medicine, 25(4), 280-293.
DOI Scopus4 WoS4 Europe PMC2
2024 Desteghe, L., & Middeldorp, M. (2024). Patient-reported outcomes in atrial fibrillation: is it worthwhile systematically evaluating?. European Journal of Cardiovascular Nursing, 23(6), e100-e101.
DOI
2024 Ariyaratnam, J. P., Mishima, R. S., Kadhim, K., Emami, M., Fitzgerald, J. L., Thiyagarajah, A., . . . Elliott, A. D. (2024). Utility and Validity of the HFA-PEFF and H2FPEF Scores in Patients With Symptomatic Atrial Fibrillation. JACC: Heart Failure, 12(6), 1015-1025.
DOI Scopus10 WoS6 Europe PMC6
2024 Lobeek, M., Middeldorp, M. E., Van Gelder, I. C., & Rienstra, M. (2024). Multimorbidity in patients with atrial fibrillation. Open Heart, 11(1), 7 pages.
DOI Scopus9 WoS10 Europe PMC11
2024 Ariyaratnam, J. P., Elliott, A. D., Mishima, R. S., Kadhim, K., Emami, M., Fitzgerald, J. L., . . . Sanders, P. (2024). Structural, Functional, and Electrical Remodelling of the Atria with Reduced Cardiorespiratory Fitness: Implications for AF. JACC: Clinical Electrophysiology, 10(7.2), 1608-1619.
DOI Scopus5 WoS3 Europe PMC3
2024 Kamsani, S. H., Middeldorp, M. E., Chiang, G., Stefil, M., Evans, S., Nguyen, M. T., . . . Sanders, P. (2024). Safety of outpatient commencement of sotalol. Heart Rhythm O2, 5(6), 341-350.
DOI Scopus1 WoS1 Europe PMC1
2024 Noubiap, J. J., Pathak, R. K., Thomas, G., Elliot, A. D., Sanders, P., & Middeldorp, M. E. (2024). Sex Differences in Outcomes of an Intensive Risk Factor Modification Program in Patients With Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology, 17(7), e012534-1-e012534-12.
DOI Scopus4 WoS3 Europe PMC2
2023 Noubiap, J. J., Thomas, G., Middeldorp, M. E., Fitzgerald, J. L., Harper, C., & Sanders, P. (2023). Atrial fibrillation detection using insertable cardiac monitor after stroke: a real-word cohort study. Journal of Cardiovascular Electrophysiology, 34(1), 142-146.
DOI Scopus7 WoS7 Europe PMC8
2023 Noubiap, J. J., Tu, S. J., Emami, M., Middeldorp, M. E., Elliott, A. D., & Sanders, P. (2023). Incident atrial fibrillation in relation to ventilatory parameters: a prospective cohort study.. Can J Cardiol, 39(5), 614-622.
DOI Scopus7 WoS7 Europe PMC4
2023 Middeldorp, M. E., & Sanders, P. (2023). Reply to the Editor — The promising future of remote monitoring for cardiac implantable electronic devices. Heart Rhythm O2, 4(4), 288-289.
DOI
2023 Heath, K., O'shea, C., Thomas, G., Harper, C., Campbell, K., Sanders, P., & Middeldorp, M. E. (2023). Impact of intensive follow-up of cardiac implantable electronic devices via remote monitoring: A pilot study.. Heart Rhythm O2, 4(2), 90-96.
DOI Scopus3 WoS3 Europe PMC3
2023 Noubiap, J. J., Thomas, G., Kamtchum-Tatuene, J., Middeldorp, M. E., & Sanders, P. (2023). High-risk carotid plaques and incident ischemic stroke in patients with atrial fibrillation in the Cardiovascular Health Study.. Eur J Neurol, 30(7), 2042-2050.
DOI
2023 Middeldorp, M. E., Kamsani, S. H., & Sanders, P. (2023). Obesity and atrial fibrillation: Prevalence, pathogenesis, and prognosis.. Progress in cardiovascular diseases, 78, S0033-0620(23)00040-3.
DOI Scopus27 WoS23 Europe PMC21
2023 Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M., & Sanders, P. (2023). Epidemiology and modifiable risk factors for atrial fibrillation. Nature Reviews Cardiology, 20(6), 404-417.
DOI Scopus246 WoS238 Europe PMC200
2023 Noubiap, J. J., & Middeldorp, M. E. (2023). Prevention of cardiac conduction disease: a long way to go. European Heart Journal, 44(12), 1067-1069.
DOI Scopus2 WoS2 Europe PMC5
2023 Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M., & Sanders, P. (2023). Author Correction: Epidemiology and modifiable risk factors for atrial fibrillation.. Nat Rev Cardiol, 20(6), 429.
DOI Scopus12 Europe PMC4
2023 Elliott, A. D., Verdicchio, C. V., Mahajan, R., Middeldorp, M. E., Gallagher, C., Mishima, R. S., . . . Sanders, P. (2023). An Exercise and Physical Activity Program in Patients With Atrial Fibrillation. JACC: Clinical Electrophysiology, 9(4), 455-465.
DOI Scopus73 WoS69 Europe PMC62
2023 O'shea, C. J., Brooks, A. G., Middeldorp, M. E., Harper, C., Hendriks, J. M., Russo, A. M., . . . Sanders, P. (2023). Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery.. J Interv Card Electrophysiol, 66(7), 1659-1668.
DOI Scopus5 WoS5 Europe PMC4
2023 Elliott, A. D., Benjamin, E. J., & Middeldorp, M. E. (2023). Prevention of atrial fibrillation: a call to action. European Heart Journal, 44(47), 4994-4996.
DOI Scopus11 WoS10 Europe PMC6
2023 Middeldorp, M. E., Sandhu, R. K., Mao, J., Gencer, B., Danik, J. S., Moorthy, V., . . . Albert, C. M. (2023). Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation: Subanalysis of the VITAL Study. Circulation Arrhythmia and Electrophysiology, 16(12), 651-662.
DOI Scopus8 WoS8
2023 Tu, S. J., Gallagher, C., Elliott, A. D., Bradbury, K. E., Marcus, G. M., Linz, D., . . . Wong, C. X. (2023). Associations of dietary patterns, ultra-processed food and nutrient intake with incident atrial fibrillation. Heart, 109(22), 1683-1689.
DOI Scopus10 WoS11 Europe PMC10
2023 Verdicchio, C. V., Mahajan, R., Middeldorp, M. E., Gallagher, C., Mishima, R. S., Lau, D. H., . . . Elliott, A. D. (2023). Influence of Sex on Efficacy of Exercise Training for Patients with Symptomatic Atrial Fibrillation: Insights from the ACTIVE-AF Randomised Controlled Trial. European Journal of Preventive Cardiology, 30(18), 2006-2014.
DOI Scopus3 WoS4 Europe PMC3
2022 Middeldorp, M. E., Lyrtzis, E., Health, K., Hall, T., Kadhim, K., & Sanders, P. (2022). Assessment of available online educational resources for patients with atrial fibrillation. Heart Rhythm O2, 4(3), 187-192.
DOI Scopus8 WoS8 Europe PMC5
2022 Noubiap Nzeale, J. J., Thomas, G., Agbaedeng, T. A., Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2022). Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States. European Heart Journal - Quality of Care and Clinical Outcomes, 8(8), 852-860.
DOI Scopus11 WoS12 Europe PMC8
2022 Hendriks, J. M., Elliott, A. D., Middeldorp, M. E., & Sanders, P. (2022). Contributing factors to personalised medicine in atrial fibrillation.. Heart, 109(3), 164-165.
DOI Scopus1 WoS1 Europe PMC1
2022 Middeldorp, M. E., Ariyaratnam, J. P., Kamsani, S. H., Albert, C. M., & Sanders, P. (2022). Hypertension and atrial fibrillation.. Journal of hypertension, 40(12), 2337-2352.
DOI Scopus14 WoS17 Europe PMC16
2022 Thiyagarajah, A., Mahajan, R., Iwai, S., Gupta, A., Linz, D., Chim, I., . . . Sanders, P. (2022). Single Ring Isolation For Atrial Fibrillation Ablation: Impact of the Learning Curve.. Journal of cardiovascular electrophysiology, 33(4), 608-617.
DOI Scopus4 WoS3 Europe PMC5
2022 Malik, V., Elliott, A. D., Thomas, G., Mishima, R. S., Pitman, B., Middeldorp, M. E., . . . Sanders, P. (2022). Autonomic Afferent Dysregulation in Atrial Fibrillation. JACC: Clinical Electrophysiology, 8(2), 152-164.
DOI Scopus19 WoS18 Europe PMC18
2022 Noubiap, J. J., Thomas, G., Nyaga, U. F., Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2022). Sex disparities in enrolment and reporting of outcomes by sex in contemporary clinical trials of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 33(5), 845-854.
DOI Scopus9 WoS9 Europe PMC10
2022 Noubiap, J. J., Middeldorp, M. E., Thomas, G., & Sanders, P. (2022). CHA₂DS₂-VASc score is no longer enough-Authors' reply. Europace, 24(7), 1195.
DOI
2022 Fitzgerald, J. L., Middeldorp, M. E., Gallagher, C., & Sanders, P. (2022). Lifestyle Modification and Atrial Fibrillation: Critical Care for Successful Ablation.. Journal of Clinical Medicine, 11(9), 2660-1-2660-17.
DOI Scopus11 WoS10 Europe PMC7
2022 Noubiap, J. J., Nyaga, U. F., Middeldorp, M. E., Fitzgerald, J. L., Ariyaratnam, J. P., Thomas, G., & Sanders, P. (2022). Frequency and prognostic significance of atrial fibrillation in acute pulmonary embolism: A pooled analysis. Respiratory Medicine, 199, 1-7.
DOI Scopus9 WoS6 Europe PMC5
2022 Verdicchio, C. V., Gallagher, C., Mahajan, R., Middeldorp, M. E., Linz, D., Lau, D. H., . . . Elliott, A. D. (2022). Use of heart rate for guiding exercise training in patients with atrial fibrillation.. J Sports Med Phys Fitness, 63(1), 188-194.
DOI Scopus1 WoS1
2022 van den Bruck, J. -H., Middeldorp, M., Sultan, A., Scheurlen, C., Seuthe, K., Woermann, J., . . . Lueker, J. (2022). Impact of ventricular arrhythmia management on suboptimal biventricular pacing in cardiac resynchronization therapy. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 66(2), 9 pages.
DOI Scopus4 WoS4 Europe PMC4
2022 Middeldorp, M. E., & Albert, C. M. (2022). Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery. European Heart Journal, 43(31), 2981-2983.
DOI Scopus1 WoS1 Europe PMC1
2022 Walfridsson, U., Walfridsson, H., Middeldorp, M. E., Sanders, P., & Årestedt, K. (2022). Validation of the English version of the arrhythmia-specific questionnaire in tachycardia and arrhythmia (ASTA): a Rasch evaluation study.. Journal of patient-reported outcomes, 6(1), 12 pages.
DOI Scopus6 WoS5 Europe PMC5
2022 Sanders, P., Kamsani, S. H., & Middeldorp, M. E. (2022). Primum Non Nocere: Serial Screening for AF, Who, How, and Why?. JACC: Clinical Electrophysiology, 8(12), 1535-1538.
DOI
2022 Thiele, H., Osto, E., Lionetti, V., Stellos, K., Madonna, R., Kraler, S., & Middeldorp, M. (2022). Welcome on board! Meet the new EHJ board reviewers. EUROPEAN HEART JOURNAL, 43(1), 9-11.
DOI
2021 Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2021). Risk factor management in atrial fibrillation : A key pillar of care. Medicine Today, 22(9), 42-49.
2021 Middeldorp, M. E., Lyrtzis, E., Heath, K. M., Hall, T., Kadhim, K., & Sanders, P. (2021). Assessment of available online educational resources for patients with atrial fibrillation (Preprint).
DOI
2021 Gallagher, C., Middeldorp, M. E., Hendriks, J. M., Lau, D. H., & Sanders, P. (2021). Lifestyle as a Risk Factor for Atrial Fibrillation.. Card Electrophysiol Clin, 13(1), 263-272.
DOI Scopus8 Europe PMC7
2021 Hendriks, J. M., Gallagher, C., Middeldorp, M. E., Lau, D. H., & Sanders, P. (2021). Risk factor management and atrial fibrillation.. Europace, 23(Supplement_2), ii52-ii60.
DOI Scopus42 WoS42 Europe PMC37
2021 Thiyagarajah, A., Mahajan, R., Iwai, S., Griffin, A., S. Mishima, R., Linz, D., . . . Sanders, P. (2021). Single ring isolation with Inferior line sparing for atrial fibrillation. Circulation: Arrhythmia and Electrophysiology, 14(4), 452-454.
DOI Scopus8 WoS8 Europe PMC9
2021 Noubiap, J. J., Agbaedeng, T. A., Kamtchum-Tatuene, J., Fitzgerald, J. L., Middeldorp, M. E., Kleinig, T., & Sanders, P. (2021). Rhythm monitoring strategies for atrial fibrillation detection in patients with cryptogenic stroke: A systematic review and meta-analysis. IJC Heart and Vasculature, 34, 1-8.
DOI Scopus35 WoS35 Europe PMC22
2021 O’Shea, C. J., Middeldorp, M. E., Thomas, G., Harper, C., Elliott, A. D., Ray, N., . . . Sanders, P. (2021). Atrial fibrillation burden during the coronavirus disease 2019 pandemic. EP Europace, 23(9), 1493-1501.
DOI Scopus26 WoS23 Europe PMC20
2021 Gallagher, C., Fitzgerald, J. L., Stokes, M. B., Noubiap, J. J., Elliott, A. D., Hendriks, J. M., . . . Lau, D. H. (2021). Risk Factor Management in Atrial Fibrillation: How to Deliver a Successful Clinic. Current Cardiovascular Risk Reports, 15(7), 9 pages.
DOI Scopus3 WoS3
2021 Noubiap, J. J., Feteh, V. F., Middeldorp, M. E., Fitzgerald, J. L., Thomas, G., Kleinig, T., . . . Sanders, P. (2021). A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation. EP-Europace, 23(10), 1528-1538.
DOI Scopus28 WoS27 Europe PMC21
2021 O'Shea, C. J., Middeldorp, M. E., Campbell, K., & Sanders, P. (2021). Cardiac defibrillator therapies during the COVID-19 pandemic: how you look provides perspective. European Heart Journal, 43(11), ehab385-1-ehab385-2.
DOI Scopus2 WoS2 Europe PMC1
2021 Noubiap, J. J., Fitzgerald, J. L., Gallagher, C., Thomas, G., Middeldorp, M. E., & Sanders, P. (2021). Rates, predictors, and impact of smoking cessation after stroke or transient ischemic attack: a systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases, 30(10), 106012-1-106012-10.
DOI Scopus29 WoS28 Europe PMC26
2021 Elliott, A. D., Middeldorp, M. E., & Linz, D. K. (2021). The ins and outs of physical activity monitoring: implications for atrial fibrillation management.. Eur Heart J, 42(38), 3989-3991.
DOI Scopus5 WoS4 Europe PMC4
2021 Kadhim, K., Middeldorp, M. E., Elliott, A. D., Agbaedeng, T., Gallagher, C., Malik, V., . . . Sanders, P. (2021). Prevalence and assessment of sleep-disordered breathing in patients with atrial fibrillation: a systematic review and meta-analysis. Canadian Journal of Cardiology, 37(11), 1846-1856.
DOI Scopus31 WoS25 Europe PMC23
2021 O'Shea, C. J., Middeldorp, M., Hendriks, J. M., Brooks, A. G., Harper, C., Thomas, G., . . . Sanders, P. (2021). Remote monitoring of implantable loop recorders: false-positive alert episode burden. Circulation: Arrhythmia and Electrophysiology, 14(11), 1048-1050.
DOI Scopus29 WoS30 Europe PMC20
2021 Emami, M., Agbaedeng, T. A., Thomas, G., Middeldorp, M. E., Thiyagarajah, A., Wong, C. X., . . . Sanders, P. (2021). Accelerated biological aging secondary to cardiometabolic risk factors is a predictor of cardiovascular mortality: a systematic review and meta-analysis. Canadian Journal of Cardiology, 38(3), 365-375.
DOI Scopus25 WoS28 Europe PMC24
2021 Elliott, A. D., Verdicchio, C. V., Gallagher, C., Linz, D., Mahajan, R., Mishima, R., . . . Sanders, P. (2021). Factors contributing to exercise intolerance in patients with atrial fibrillation. Heart, Lung and Circulation, 30(7), 947-954.
DOI Scopus21 WoS20 Europe PMC19
2021 O’Shea, C. J., Thomas, G., Middeldorp, M. E., Harper, C., Elliott, A. D., Ray, N., . . . Sanders, P. (2021). Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic. European Heart Journal, 42(5), 520-528.
DOI Scopus50 WoS48 Europe PMC37
2021 Mishima, R. S., Verdicchio, C. V., Noubiap, J. J., Ariyaratnam, J. P., Gallagher, C., Jones, D., . . . Elliott, A. D. (2021). Self-reported Physical Activity and Atrial Fibrillation Risk: A Systematic Review and Meta-analysis. Heart Rhythm, 18(4), 520-528.
DOI Scopus34 WoS33 Europe PMC30
2021 Middeldorp, M. E., Gupta, A., Elliott, A., Kadhim, K., Thiyagarajah, A., Gallagher, C., . . . Sanders, P. (2021). Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Heart (British Cardiac Society), 107(12), 971-976.
DOI Scopus1 WoS1 Europe PMC1
2021 Iacopo, F., Branch, M., Cardinale, D., Middeldorp, M., Sanders, P., Cohen, J. B., . . . Brown, S. A. (2021). Preventive Cardio-Oncology: Cardiovascular Disease Prevention in Cancer Patients and Survivors. Current Treatment Options in Cardiovascular Medicine, 23(1), 1-23.
DOI Scopus11 WoS5
2020 Gallagher, C., Wong, C. X., Hendriks, J. M., Nyfort-Hansen, K., Rowett, D., Bednarz, J., . . . Sanders, P. (2020). Opportunities to reduce the risk of stroke in AF: the REVIEW AF study. European Heart Journal, 41(Supplement_2), 3427.
DOI
2020 Rocheleau, S., Gallagher, C., Pitman, B. M., Tu, S. J., Hanna-Rivero, N., Clarke, N., . . . Wong, C. X. (2020). Predictors of anticoagulation use in indigenous and non-indigenous Australians with atrial fibrillation. Heart Lung and Circulation, 30(5), 707-713.
DOI
2020 O'shea, C. J., Middeldorp, M. E., Hendriks, J. M., Brooks, A. G., Lau, D. H., Emami, M., . . . Sanders, P. (2020). Remote monitoring alert burden: an analysis of transmission in >26,000 patients. JACC: Clinical Electrophysiology, 7(2), 226-234.
DOI Scopus62 WoS57 Europe PMC49
2020 Middeldorp, M. E., Ariyaratnam, J., Lau, D., & Sanders, P. (2020). Lifestyle modifications for treatment of atrial fibrillation. Heart, 106(5), 325-332.
DOI Scopus95 WoS86 Europe PMC77
2020 Noubiap, J. J., Agbaedeng, T. A., Tochie, J. N., Nkeck, J. R., Ndoadoumgue, A. L., Fitzgerald, J. L., . . . Sanders, P. (2020). Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa. The American Journal of Cardiology, 138, 72-79.
DOI Scopus18 WoS18 Europe PMC15
2020 Elliott, A. D., Linz, D., Mishima, R., Kadhim, K., Gallagher, C., Middeldorp, M. E., . . . Sanders, P. (2020). Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort. European Heart Journal, 41(15), 1479-1486.
DOI Scopus141 WoS136 Europe PMC121
2020 Gallagher, C., Nyfort-Hansen, K., Rowett, D., Wong, C. X., Middeldorp, M. E., Mahajan, R., . . . Hendriks, J. M. (2020). Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis. Open Heart, 7(1), 9 pages.
DOI Scopus50 WoS44 Europe PMC40
2020 Ariyaratnam, J. P., Middeldorp, M., Thomas, G., Noubiap Nzeale, J. J. N., Lau, D., & Sanders, P. (2020). Risk factor management before and after atrial fibrillation ablation. Cardiac Electrophysiology Clinics, 12(2), 141-154.
DOI Scopus8 Europe PMC7
2020 Middeldorp, M. E., Elliott, A. D., Gallagher, C., Linz, D., Hendriks, J. M. L., Mahajan, R., . . . Sanders, P. (2020). Late-onset thyrotoxicosis after the cessation of amiodarone. Indian Pacing and Electrophysiology Journal, 20(6), 265-268.
DOI Scopus1 Europe PMC2
2020 Heath, K. M., Lyrtzis, E., Middeldorp, M. E., Sanders, P., & Lau, D. H. (2020). False remote monitoring alerts from explanted cardiac implantable electronic device: How is this possible?. Journal of Electrocardiology, 62, 132-133.
DOI
2019 Nguyen, M. T., Gallagher, C., Pitman, B. M., Emami, M., Kadhim, K., Hendriks, J. M., . . . Wong, C. X. (2019). Quality of warfarin anticoagulation in indigenous and non-indigenous Australians with atrial fibrillation. Heart, Lung and Circulation, 29(8), 1122-1128.
DOI Scopus8 WoS8 Europe PMC7
2019 Pluymaekers, N. A. H. A., Hermans, A. N. L., Middeldorp, M. E., Kadhim, K., Crijns, H. J. G. M., Sanders, P., & Linz, D. (2019). Gender differences and daily variation in atrial fibrillation risk factor profiles: Considerations for risk factor management. Ijc Heart and Vasculature, 25, 3 pages.
DOI Scopus4 WoS3 Europe PMC3
2019 Gallagher, C., Middeldorp, M. E., & Sanders, P. (2019). Weight and risk of incident atrial fibrillation—body mass index variability or body mass gain?. Mayo Clinic Proceedings, 94(2), 186-188.
DOI Scopus1 WoS1 Europe PMC1
2019 Middeldorp, M. E., Pathak, R. K., Lau, D. H., & Sanders, P. (2019). Prevention and regressive effect of weight-loss and risk factor modification on atrial fibrillation: the reverse-AF study - authors' reply. Europace, 21(6), 990-991.
DOI Scopus8 WoS7 Europe PMC7
2019 Linz, D., Brooks, A. G., Elliott, A. D., Nalliah, C. J., Hendriks, J. M. L., Middeldorp, M. E., . . . Sanders, P. (2019). Variability of Sleep Apnea Severity and Risk of Atrial Fibrillation: The VARIOSA-AF Study. JACC: Clinical Electrophysiology, 5(6), 692-701.
DOI Scopus101 WoS90 Europe PMC68
2019 Hendriks, J. M., Brooks, A. G., Rowett, D., Moss, J. R., Gallagher, C., Nyfort-Hansen, K., . . . Sanders, P. (2019). Home-based education and learning program for atrial fibrillation: rationale and design of the HELP-AF study. Canadian Journal of Cardiology, 35(7), 846-854.
DOI Scopus18 WoS18 Europe PMC14
2019 Middeldorp, M. E., Wong, C. X., Gallagher, C., Elliott, A. D., Lau, D. H., & Sanders, P. (2019). No time to weight: obesity through life and AF risk. European Heart Journal, 40(34), 2867-2869.
DOI Scopus2 WoS2 Europe PMC1
2019 Kadhim, K., Middeldorp, M. E., Hendriks, J. M., Lau, D. H., & Sanders, P. (2019). Bariatric surgery and atrial fibrillation: does the end justify the means?. EP Europace, 21(10), 1454-1456.
DOI Scopus3 WoS2 Europe PMC2
2019 Gallagher, C., Hendriks, J. M., Middeldorp, M. E., Elliott, A. D., Lau, D. H., & Sanders, P. (2019). Reducing the burden of atrial fibrillation cost: is integrated care the answer?. Canadian Journal of Cardiology, 35(9), 1094-1096.
DOI Scopus7 WoS6 Europe PMC4
2019 Malik, V., Lau, D. H., Linz, D., Middeldorp, M. E., & Sanders, P. (2019). Is the stomach a way to one's heart? Gastric autonomic activity and AF susceptibility in gastro-esophageal reflux disease. Journal of Cardiovascular Electrophysiology, 30(11), 2271-2273.
DOI Scopus1 WoS1 Europe PMC1
2019 Kadhim, K., Middeldorp, M. E., Elliott, A. D., Jones, D., Hendriks, J. M. L., Gallagher, C., . . . Linz, D. (2019). Self-reported daytime sleepiness and sleep-disordered breathing in patients with atrial fibrillation: SNOozE-AF. The Canadian Journal of Cardiology, 35(11), 1457-1464.
DOI Scopus60 WoS57 Europe PMC47
2019 Gallagher, C., Rowett, D., Nyfort-Hansen, K., Simmons, S., Brooks, A. G., Moss, J. R., . . . Sanders, P. (2019). Patient-centered educational resources for atrial fibrillation. JACC: Clinical Electrophysiology, 5(10), 1101-1114.
DOI Scopus21 WoS20 Europe PMC16
2019 Middeldorp, M. E., Lau, D. H., & Sanders, P. (2019). Is bypassing traditional weight-loss the answer for atrial fibrillation?. Circulation Arrhythmia and Electrophysiology, 12(10), 3 pages.
DOI Scopus2 WoS3 Europe PMC2
2019 Elliott, A. D., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2019). Drinking to atrial fibrillation: alcohol and atrial fibrillation incidence. EP-Europace, 22(2), 177-178.
DOI Scopus1 WoS1 Europe PMC1
2019 Gallagher, C., Hendriks, J. M. L., Giles, L., Karnon, J., Pham, C., Elliott, A. D., . . . Wong, C. X. (2019). Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart, 105(17), 1358-1363.
DOI Scopus68 WoS60 Europe PMC52
2019 Rangnekar, G., Gallagher, C., Wong, G. R., Rocheleau, S., Brooks, A. G., Hendriks, J. M. L., . . . Lau, D. H. (2019). Oral anticoagulation therapy in atrial fibrillation patients managed in the emergency department compared to cardiology outpatient: opportunities for improved outcomes. Heart Lung and Circulation, 28(4), 43-46.
DOI Scopus6 WoS5 Europe PMC3
2018 Middeldorp, M., Pathak, R., Meredith, M., Mehta, A., Elliott, A., Mahajan, R., . . . Sanders, P. (2018). PREVEntion and regReSsive effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. Europace, 20(12), 1929-1935.
DOI Scopus318 WoS290 Europe PMC245
2018 Hendriks, J. M., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2018). New approaches to detection of atrial fibrillation. Heart, 104(23), 1898-1899.
DOI Scopus4 WoS3 Europe PMC3
2018 Linz, D., Kadhim, K., Brooks, A. G., Elliott, A. D., Hendriks, J. M. L., Lau, D. H., . . . Sanders, P. (2018). Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients. International Journal of Cardiology, 272, 155-161.
DOI Scopus38 WoS36 Europe PMC27
2018 Munawar, D., Mahajan, R., Linz, D., Wong, G., Khokhar, K., Thiyagarajah, A., . . . Lau, D. (2018). Predicted longevity of contemporary cardiac implantable electronic devices: a call for industry-wide “standardized” reporting. Heart Rhythm, 15(12), 1756-1763.
DOI Scopus35 WoS32 Europe PMC27
2018 Mahajan, R., Perera, T., Elliott, A. D., Twomey, D. J., Kumar, S., Munwar, D. A., . . . Sanders, P. (2018). Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. European Heart Journal, 39(16), 1407-1415.
DOI Scopus243 WoS231 Europe PMC185
2018 Elliott, A. D., Mahajan, R., Linz, D., Stokes, M., Verdicchio, C. V., Middeldorp, M. E., . . . Sanders, P. (2018). Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation. Clinical Cardiology, 41(6), 843-848.
DOI Scopus37 WoS32 Europe PMC32
2018 Mahajan, R., Nelson, A., Pathak, R. K., Middeldorp, M. E., Wong, C. X., Twomey, D. J., . . . Sanders, P. (2018). Electroanatomical remodeling of the atria in obesity: impact of adjacent epicardial fat. JACC: Clinical Electrophysiology, 4(12), 1529-1540.
DOI Scopus137 WoS129 Europe PMC106
2017 Middeldorp, M., Mahajan, R., Elliott, A., Pathak, R., Twomey, D., Wilson, L., . . . Sanders, P. (2017). Premature Trigger of ERI in Medtronic EnRhythm Devices. PACE - Pacing and Clinical Electrophysiology, 40(6), 624-628.
DOI Scopus1 WoS1 Europe PMC1
2017 Pathak, R., Evans, M., Middeldorp, M., Mahajan, R., Mehta, A., Meredith, M., . . . Sanders, P. (2017). Cost-effectiveness and clinical effectiveness of the risk factor management clinic in atrial fibrillation: the CENT study. JACC: Clinical Electrophysiology, 3(5), 436-447.
DOI Scopus76 Europe PMC57
2017 Gallagher, C., Elliott, A., Wong, C., Rangnekar, G., Middeldorp, M., Mahajan, R., . . . Hendriks, J. (2017). Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart, 103(24), 1947-1953.
DOI Scopus179 WoS154 Europe PMC131
2017 Gallagher, C., Hendriks, J., Elliott, A., Wong, C., Rangnekar, G., Middeldorp, M., . . . Sanders, P. (2017). Alcohol and incident atrial fibrillation – a systematic review and meta-analysis. International Journal of Cardiology, 246, 46-52.
DOI Scopus147 WoS117 Europe PMC102
2016 Lim, H. S., Denis, A., Middeldorp, M. E., Lau, D. H., Mahajan, R., Derval, N., . . . Haïssaguerre, M. (2016). Persistent atrial fibrillation from the onset: a specific subgroup of patients with biatrial substrate involvement and poorer clinical outcome. JACC: Clinical Electrophysiology, 2(2), 129-139.
DOI Scopus24 Europe PMC14
2016 Gallagher, C., Hendriks, J., Mahajan, R., Middeldorp, M., Elliott, A., Pathak, R., . . . Lau, D. (2016). Lifestyle management to prevent and treat atrial fibrillation. Expert Review of Cardiovascular Therapy, 14(7), 799-809.
DOI Scopus28 WoS23 Europe PMC18
2016 Lau, D., Middeldorp, M., & Sanders, P. (2016). Obesity paradox in atrial fibrillation: a distracting reality or fictitious finding?. European Heart Journal, 37(38), 2879-2881.
DOI Scopus13 WoS12 Europe PMC11
2016 Wong, G., Lau, D., Middeldorp, M., Harrington, J., Stolcman, S., Wilson, L., . . . Sanders, P. (2016). Feasibility and safety of Reveal LINQ insertion in a sterile procedure room versus electrophysiology laboratory. International Journal of Cardiology, 223, 13-17.
DOI Scopus24 WoS21 Europe PMC21
2016 Wong, G. R., Munawar, D. A., Twomey, D. J., Kumar, S., Middeldorp, M. E., Chapman, D., . . . Lau, D. H. (2016). Projected longevity of contemporary cardiac pacemakers: differences and impact of advanced pacing features. EUROPEAN HEART JOURNAL, 37, 1301-1302.
2015 Wong, G. R., Lau, D. H., Baillie, T. J., Middeldorp, M. E., Steele, P. M., & Sanders, P. (2015). Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'. International Journal of Cardiology, 181, 55-56.
DOI Scopus12 WoS11 Europe PMC11
2015 Pathak, R., Middeldorp, M., Meredith, M., Mehta, A., Mahajan, R., Wong, C., . . . Sanders, P. (2015). Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). Journal of the American College of Cardiology, 65(20), 2159-2169.
DOI Scopus824 WoS751 Europe PMC658
2015 Pathak, R., Elliott, A., Middeldorp, M., Meredith, M., Mehta, A., Mahajan, R., . . . Sanders, P. (2015). Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT Study. Journal of the American College of Cardiology, 66(9), 985-996.
DOI Scopus455 WoS412 Europe PMC359
2015 Wong, C., Sullivan, T., Sun, M., Mahajan, R., Pathak, R., Middeldorp, M., . . . Sanders, P. (2015). Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC: Clinical Electrophysiology, 1(3), 139-152.
DOI Scopus280 Europe PMC203
2014 Pathak, R., Middeldorp, M., Lau, D., Mehta, A., Mahajan, R., Twomey, D., . . . Sanders, P. (2014). Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF Cohort Study. Journal of the American College of Cardiology, 64(21), 2222-2231.
DOI Scopus795 WoS706 Europe PMC638
2013 Abed, H., Wittert, G., Leong, D., Shirazi, M., Bahrami, B., Middeldorp, M., . . . Sanders, P. (2013). Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation a randomized clinical trial. Jama-journal of the American Medical Association, 310(19), 2050-2060.
DOI Scopus655 WoS639 Europe PMC522
2013 Lau, D., Middeldorp, M., Brooks, A., Ganesan, A., Roberts-Thomson, K., Stiles, M., . . . Sanders, P. (2013). Aortic stiffness in lone atrial fibrillation: A novel risk factor for arrhythmia recurrence. PLoS One, 8(10), 1-9.
DOI Scopus48 WoS42 Europe PMC44
2013 Nayyar, S., Middeldorp, M., Roberts-Thomson, K., & Sanders, P. (2013). Clatter on the electrocardiogram. Journal of Electrocardiology, 46(1), 66-68.
DOI
2012 Brooks, A., Rangnekar, G., Ganesan, A., Salna, I., Middeldorp, M., Kuklik, P., . . . Sanders, P. (2012). Characteristics of ectopic triggers associated with paroxysmal and persistent atrial fibrillation: evidence for a changing role. Heart Rhythm, 9(9), 1367-1374.
DOI Scopus14 WoS13 Europe PMC13
2011 Wong, C., Abed, H., Molaee, P., Nelson, A., Brooks, A., Sharma, G., . . . Sanders, P. (2011). Pericardial fat is associated with atrial fibrillation severity and ablation outcome. Journal of the American College of Cardiology, 57(17), 1745-1751.
DOI Scopus402 WoS363 Europe PMC308
2011 Lau, D. H., Middeldorp, M. E., Brooks, A. G., Stiles, M. K., Leong, D. P., Ganesan, A. N., . . . Sanders, P. (2011). Aortic stiffness is associated with atrial fibrillation recurrence following ablation in lone atrial fibrillation patients. EUROPEAN HEART JOURNAL, 32, 621.

Year Citation
2024 Fitzgerald, J., Shahmohamadi, E., Emami, M., Middeldorp, M., Elliott, A., Gallagher, C., . . . Sanders, P. (2024). Intensive Risk Factor Modification for Secondary Prevention of Ischemic Stroke - a Feasibility Study. In CIRCULATION Vol. 150 (pp. 2 pages). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
DOI
2024 Dziano, J., Howie, J., Ariyaratnam, J., Middeldorp, M., Emami, M., Mishima, R., . . . Elliott, A. (2024). Abnormalities in Cardiopulmonary Exercise Test Associated With More Advance Atrial Cardiomyopathy. In Heart Lung and Circulation Vol. 33 (pp. S146-S147). Elsevier BV.
DOI
2024 Shahmohamadi, E., Middeldorp, M., Ariyaratnam, J., Jayakumar, M., Fitzgerald, J., Elliott, A., & Sanders, P. (2024). Ethnic differences in Body Mass Index Cut-off Values Associated with Cardiovascular Risks in South Asians Compared to White Population: A Systematic Review and Meta-analysis. In CIRCULATION Vol. 150 (pp. 3 pages). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
DOI
2023 Mao, J., Middeldorp, M., Moorthy, M. V., Siddiqi, H. K., Sandhu, R. K., Cheng, S., . . . Albert, C. M. (2023). PREDICTORS OF NEW ONSET ASYMPTOMATIC ATRIAL FIBRILLATION: A VITAL RHYTHM STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 81 (pp. 124). LA, New Orleans: ELSEVIER SCIENCE INC.
2023 Middeldorp, M., Sandhu, R. K., Mao, J., Gencer, B., Danik, J. S., Moorthy, M. V., . . . Albert, C. M. (2023). RISK FACTORS ASSOCIATED WITH INCIDENT PERSISTENT ATRIAL FIBRILLATION AT TIME OF DIAGNOSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 81 (pp. 137). LA, New Orleans: ELSEVIER SCIENCE INC.
2021 Gallagher, C., Rowett, D., Nyfort-Hansen, K., Simmons, S., Bulto, L., Middeldorp, M. E., . . . Hendriks, J. M. (2021). Development and validation of a questionnaire to assess knowledge in patients with Atrial Fibrillation. In EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Vol. 20 (pp. 7). OXFORD UNIV PRESS.
DOI
2020 Walfridsson, U., Middeldorp, M., Walfridsson, H., Sanders, P., & Arestedt, K. (2020). Validation of the English version of the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA). In EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Vol. 19 (pp. S41). SAGE PUBLICATIONS LTD.
2017 Mahajan, R., Lew, L., Koh, Y. H., Khokkar, K., Elliott, A. D., Gallagher, C., . . . Sanders, P. (2017). Cognitive impairment and dementia in atrial fibrillation: a meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 984). OXFORD UNIV PRESS.
2017 Ramkumar, S., Yang, H., Middeldorp, M., Sanders, P., & Marwick, T. H. (2017). Use of left atrial strain for risk stratification in atrial fibrillation with low clinical thromboembolic risk. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 884-885). OXFORD UNIV PRESS.
2017 Middeldorp, M. E., Elliott, A. D., Gallagher, C., Hendricks, J., Munawar, A., Khokhar, K., . . . Sanders, P. (2017). The influence of gender on 1-year outcomes of patients undergoing primary AF ablation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 39). Barcelona, SPAIN: OXFORD UNIV PRESS.
2015 Wong, C. X., Sullivan, T., Sun, M. T., Mahajan, R., Pathak, R. K., Middeldorp, M., . . . Sanders, P. (2015). Body mass index and recurrent atrial fibrillation following catheter ablation: a meta-analysis. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 737-738). London, ENGLAND: OXFORD UNIV PRESS.
2015 Pathak, R. K., Middeldorp, M. E., Stolcman, S., Willoughby, S., Mahajan, R., Lau, D. H., & Sanders, P. (2015). Aggressive Risk factor REduction STudy: Implications for the Substrate for Atrial Fibrillation (ARREST-AF Substrate Study). In CIRCULATION Vol. 132 (pp. 4 pages). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
WoS4

Year Citation
2024 Ariyaratnam, J., Elliott, A. D., Mishima, R. S., Emami, M., Kadhim, K., Middeldorp, M. E., & Sanders, P. (2024). Invasive haemodynamic assessment shows the obesity-HFpEF phenotype is common amongst patients with symptomatic AF. Poster session presented at the meeting of Abstracts of the European Society of Cardiologists ESC Congress 2024, as published in European Heart Journal. London, UK: Oxford University Press.
DOI
2024 Stefil, M., O'shea, C. J., Middeldorp, M., Hendriks, J. M., Lau, D. H., Emami, M., . . . Sanders, P. (2024). Remote monitoring of implantable cardioverter defibrillators: a systematic review and meta-analysis of randomised controlled trials. Poster session presented at the meeting of Abstracts of the European Society of Cardiologists ESC Congress 2024, as published in European Heart Journal. London, UK: Oxford University Press.
DOI
2024 Pathak, R., Elliott, A., Lau, D., Middeldorp, M., Linz, D., Fitzgerald, J., . . . Sanders, P. (2024). Aggressive Risk factor REduction STudy for Atrial Fibrillation (ARREST-AF) implications for ablation outcomes: A Randomized Clinical Trial. Poster session presented at the meeting of Abstracts of the American Heart Association Resuscitation Science Symposium 2024, as published in Circulation. Chicago, IL: Lippincott Williams & Wilkins.
DOI
2023 Elliott, A., Verdicchio, C. V., Mahajan, R., Gallagher, C., Lau, D. H., Middeldorp, M. E., & Sanders, P. (2023). Impact of atrial fibrillation type on outcomes following aerobic exercise training: analysis from the ACTIVE-AF Trial. Poster session presented at the meeting of Abstracts of the European Society of Cardiology Congress (ESC 2023), as published in European Heart Journal. Amsterdam and virtual online: Oxford University Press (OUP).
DOI
2022 Elliott, A. D., Verdicchio, C., Mahajan, R., Middeldorp, M. E., Gallagher, C., Lau, D. H., & Sanders, P. (2022). Impact of Sex on Outcomes Following Aerobic Exercise Training in Patients With Symptomatic Atrial Fibrillation. Poster session presented at the meeting of CIRCULATION. Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
2019 Kadhim, K., Elliott, A., Middeldorp, M., Hendriks, J., Gallagher, C., Mahajan, R., . . . Linz, D. (2019). MOODS: a novel risk score to identify patients with atrial fibrillation and sleep apnoea. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS.
2019 Linz, D., Nalliah, C., Baumert, M., Kadhim, K., Middeldorp, M., Elliott, A., . . . Sanders, P. (2019). Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS.
2019 Middeldorp, M. E., Elliott, A., Lau, D. H., & Sanders, P. (2019). Is Cessation of Anticoagulation Safe Post Successful AF Ablation: Late Occurrence of Thromboembolic Events. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS.
2017 Hendriks, J. M. L., Gallagher, C., Mahajan, R., Elliott, A., Middeldorp, M. E., Lau, D., & Sanders, P. (2017). Integrated Care Management in Atrial Fibrillation is associated with improved outcomes - a systematic review and meta-analysis. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF INTEGRATED CARE. UBIQUITY PRESS LTD.
DOI

 

  1. Title: Centre of Research Excellence for Atrial Fibrillation (AF-CARE) to Reduce Burden of Disease
  2. Start date: 27 Jan 2026
  3. End date: 31 Dec 2030
  4. Funding scheme: NHMRC - Centres of Research Excellence
  5. Funder: National Health and Medical Research Council
  6. Total Awarded Amount: AUD $3,000,000
  7. Co-investigator

  1. Title: Establishing the Atrial Fibrillation Ablation National Cardiac Registry (AF-NCR)
  2. Start Date: 01 Apr 2025
  3. End date: 31 Mar 2031
  4. Funding Scheme: MRFF Enhancing Medical Device Surveillance Through Registries
  5. Funder: National Health and Medical Research Council
  6. Total Awarded Amount: AUD 6,999,911.6
  7. Co-investigator

  1. Title: Increasing Pacing Rate Amongst Patients with Heart Failure with Preserved Ejection Fraction: the PACE-UP Study
  2. Start date: 01 Jan 2024
  3. End date: 31 Dec 2025
  4. Funding scheme: Heart Foundation - Vanguard Grants
  5. Funder name: National Heart Foundation of Australia
  6. Total Awarded Amount: AUD $148,800
  7. Co-investigator

  1. Title: Improving Acute Atrial Fibrillation Management for better patient outcomes
  2. Start date: 01 Apr 2022
  3. End date: 31 Mar 2025
  4. Funding scheme: FND000838: MRFF - Emerging Priorities & Consumer Driven Research Initiative
  5. Funder name: National Health and Medical Research Council
  6. Total Awarded Amount: AUD $999,996
  7. Co-investigator

  1. Title: Epidemiology, risk factors, progression and AF
  2. Start Date: 01 Jul 2021
  3. End date: 30 Jun 2022
  4. Funding Scheme: AAUW International Postdoctoral Fellowship
  5. Funder: American Association for University Women
  6. Total Awarded Amount: USD $30,000
  7. Primary investigator

  1. Title: HRS Afib Awareness
  2. Start Date: 12 Sep 2016
  3. End date: 18 Sep 2016
  4. Funding Scheme: Afib Awareness Funding Grant
  5. Funder: Heart Rhythm Society
  6. Total Awarded Amount: USD $5,000
  7. Primary investigator

  1. Title: Weight and risk factor management and assessment of socioeconomic status to assess impact on AF progression
  2. Start date: 1 Jan 2017
  3. End date: 31 Dec 2019
  4. Funding scheme: NHMRC - Postgraduate Scholarships Grant
  5. Funder: National Health and Medical Research Council
  6. Total Awarded Amount: AUD $86,117.00
  7. Primary investigator

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor GEN-REF Study - Gender-based differences in referral to catheter ablation study Doctor of Philosophy Doctorate Full Time Ms Melanie Gunawardene
2025 Co-Supervisor Efficacy of Combined Risk Factor Interventions for Atrial Fibrillation Master of Philosophy (Clinical Science) Master Full Time Dr Hidehiro Iwakawa
2024 Co-Supervisor PREDICTive value of aggressive risk factor modification on the occurrence of major cardiovascular events in patients with embolic STROKE (PREDICT-STROKE) Doctor of Philosophy Doctorate Full Time Dr Elnaz Shahmohamadi
2024 Co-Supervisor Redesigning care with an Emergency Department protocol and rapid access clinic to reduce hospitalisations for Atrial Fibrillation (REDUCE-AF) Master of Philosophy (Clinical Science) Master Full Time Dr Alessandra Pina
2023 Co-Supervisor Efficacy of personalised exercise for the reduction of cardiovascular risk and primary prevention of cardiovascular disease Doctor of Philosophy Doctorate Full Time Mrs Jenelle Kay Dziano
2023 Co-Supervisor The effects of exercise-based rehabilitation on atrial fibrillation recurrence following catheter ablation Doctor of Philosophy Doctorate Full Time Mr Jackson Oliver Howie
2023 Co-Supervisor Advances in diagnostic and therapeutic cardiology provided by big data and machine learning Doctor of Philosophy Doctorate Full Time Shaun Christopher Evans
2023 Co-Supervisor Predict Stroke - Will closer/proper risk factor management in patients with previous stroke prevents them from getting another stroke? Doctor of Philosophy Doctorate Full Time Mr Mohanaraj Jayakumar
2023 Co-Supervisor Approaches to monitoring and management of cardiac arrhythmias Doctor of Philosophy Doctorate Full Time Dr Suraya Hani Binti Kamsani

Date Role Research Topic Program Degree Type Student Load Student Name
2019 - 2023 Co-Supervisor Screening, risk stratification, and management of atrial fibrillation Doctor of Philosophy Doctorate Full Time Dr Jean Jacques Noubiap Nzeale
2019 - 2024 Co-Supervisor Remote Monitoring of Cardiac Implantable Electronic Devices: Characterisation of Clinical Burden, Use in Arrhythmia Detection and Impact on Patient Outcomes Doctor of Philosophy Doctorate Full Time Dr Catherine O'shea

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2020 - 2020 Principal Supervisor Population screening for atrial fibrillation and stroke risk using eHealth technology Universty of Adelaide MBBS Other - Sharadi Wijesinghe
2020 - 2020 Principal Supervisor Population screening for atrial fibrillation and stroke risk using eHealth technology Universty of Adelaide MBBS Other - Phoebe Chao
2020 - 2020 Principal Supervisor Population screening for atrial fibrillation and stroke risk using eHealth technology Universty of Adelaide MBBS Other - Samiksha Mali
2020 - 2020 Principal Supervisor Population screening for atrial fibrillation and stroke risk using eHealth technology Universty of Adelaide MBBS Other - Xin Lee
2019 - 2019 Principal Supervisor Impact of Lipids on AF Development University of Adelaide MBBS Other - Tri Nguyen
2019 - 2019 Principal Supervisor Impact of Lipids on AF developement University of Adelaide MBBS Other - Gabriel Lapaglia
2019 - 2019 Principal Supervisor Impact of Lipids on AF Development University of Adelaide MBBS Other - Tanishq Mathur
2019 - 2019 Principal Supervisor Impact of Lipids on AF Development University of Adelaide MBBS Other - Thisun Gange
2019 - 2019 Principal Supervisor Role of Yoga in Atrial Fibrillation University of Adelaide MBBS Other - Ayra Perakath
2019 - 2019 Principal Supervisor Role of Yoga and Atrial Fibrillation University of Adelaide MBBS Other - Elena Te
2019 - 2019 Principal Supervisor Role of Yoga and Atrial Fibrillation University of Adelaide MBBS Other - Meg Schulz
2019 - 2019 Principal Supervisor Role of Yoga and Atrial Fibrillation University of Adelaide MBBS Other - Shyanne Premnath

Date Topic Location Name
2021 - 2021 Honours: Impact of intensive follow-up of cardiac implantable electronic devices via remote monitoring: a pilot study University of Adelaide Kyle Heath

Date Role Committee Institution Country
2024 - ongoing Member CSANZ Heart Rhythm Council Cardiac Society of Australia and New Zealand Australia
2024 - ongoing Member Heart Rhythm Society Digital Education Committee Heart Rhythm Society United States
2024 - ongoing Member Heart Rhythm Society Allied Professional Council Heart Rhythm Society United States
2023 - ongoing Board Member Asia Pacific Heart Rhythm Society Program Comittee Asia Pacific Heart Rhythm Society Australia
2023 - ongoing Member Heart Rhythm Society Quality Improvement Committee Heart Rhythm Society United States
2020 - ongoing Member Heart Rhythm Society Leadership and Education in Allied Professional Program Heart Rhythm Society United States

Date Role Membership Country
2019 - ongoing Member American Heart Association United States
2018 - ongoing Member European Heart Rhythm Association France
2017 - ongoing Member Asia Pacific Heart Rhythm Society Singapore
2017 - ongoing Member European Society of Cardiology France
2015 - ongoing Member Heart Rhythm Society United States

Date Engagement Type Partner Name
2021 - ongoing Consultant Fibricheck
2019 - ongoing Consultant Pacemate

Date Title Type Institution Country
2025 - ongoing Abstract Grading: European Society of Cardiology 2025 Peer Review European Society of Cardiology -
2024 - ongoing Abstract Grader: Heart Rhythm Society 2025 Peer Review Heart Rhythm Society -
2024 - ongoing Abstract Grader: Asia Pacific Heart Rhythm Society 2024 Peer Review Asia Pacific Heart Rhythm Society -
2024 - ongoing Abstract Grading: European Society of Cardiology 2024 Peer Review European Society of Cardiology -
2024 - ongoing Abstract Grading: Heart Rhythm Society 2024 Peer Review Heart Rhythm Society -
2023 - ongoing Abstract Grading: Annual Scientific of the Heart Rhythm Society 2023 Peer Review Heart Rhythm Society -
2022 - ongoing Abstract Grading: Annual Scientific of the Heart Rhythm Society 2022 Peer Review Heart Rhythm Society -
2021 - ongoing Abstract Grading: Annual Scientific of the Heart Rhythm Society 2021 Peer Review Heart Rhythm Society -
2020 - ongoing Clinical Medicine Insights: Cardiology Journal Review Clinical Medicine Insights: Cardiology -
2020 - ongoing PLOS ONE Journal Review PLOS ONE -
2020 - ongoing European Heart Journal Journal Review European Heart Journal -
2020 - ongoing The American Journal of Cardiology Journal Review The American Journal of Cardiology -
2020 - ongoing International Journal of Cardiology-Heart and Vasculature Journal Review International Journal of Cardiology-Heart and Vasculature -
2020 - ongoing Expert Review of Medical Devices Journal Review Expert Review of Medical Devices -
2020 - ongoing BMC Medicine Journal Review BMC Medicine -
2020 - ongoing Abstract Grading: Annual Scientific of the Heart Rhythm Society 2020 Peer Review Heart Rhythm Society -
2019 - ongoing Clinical Cardiology Journal Review Clinical Cardiology -
2019 - ongoing Journal of Cardiovascular Electrophysiology Journal Review Journal of Cardiovascular Electrophysiology United States
2019 - ongoing Journal of the American College of Cardiology Peer Review American College of Cardiology United States
2019 - ongoing The American Heart Journal Peer Review American Heart United States
2019 - ongoing Pacing and Clinical Electrophysiology Peer Review PACE United States
2018 - ongoing Journal of Interventional Cardiac Electrophysiology Peer Review ECAS United States

Connect With Me

External Profiles

Other Links